Shanghai Runda Med Tech Co Capital Reinvestment Ratio

Latest as of June 2023: 0.47x

Shanghai Runda Med Tech Co capital reinvestment ratio. Shanghai Runda Med Tech Co (603108) has a Capital Reinvestment Ratio of 0.47x as of June 2023, meaning it reinvests 0% of its operating cash flow (CN¥144.38 Million) in capital expenditures (CN¥68.54 Million). See Shanghai Runda Med Tech Co free cash flow efficiency to measure how efficiently the company converts operating cash flow to free cash.

Capital Reinvestment Ratio

0.47x
Capex / Operating Cash Flow

Operating Cash Flow

CN¥144.38 Million
CNY

Capital Expenditures

CN¥68.54 Million
CNY

Data as of

Jun 2023
Most recent filing

Capital Reinvestment Ratio of Shanghai Runda Med Tech Co (2014–2024)

Capital reinvestment ratio of Shanghai Runda Med Tech Co from 2014 to 2024. This chart tracks Shanghai Runda Med Tech Co's Capital Reinvestment Ratio across 7 annual periods. See Shanghai Runda Med Tech Co leverage flexibility ratio to measure the company's free cash flow as a share of total liabilities.

Shanghai Runda Med Tech Co Capital Reinvestment Ratio by Year (2014–2024)

Shanghai Runda Med Tech Co capital reinvestment ratio by year from 2014 to 2024. For the full cash flow conversion analysis, see cash efficiency ratio of Shanghai Runda Med Tech Co.

Year Reinvestment Ratio Operating CF (CNY) Capital Expenditures YoY Change
2024 0.35x CN¥646.95 Million CN¥229.16 Million ▼ -19.2%
2023 0.44x CN¥729.72 Million CN¥319.88 Million ▼ -46.0%
2021 0.81x CN¥371.11 Million CN¥301.09 Million ▼ -20.9%
2020 1.03x CN¥323.44 Million CN¥331.94 Million ▼ -12.3%
2019 1.17x CN¥246.68 Million CN¥288.73 Million ▲ +138.5%
2018 0.49x CN¥538.90 Million CN¥264.43 Million ▼ -85.9%
2014 3.47x CN¥36.11 Million CN¥125.35 Million —
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow